CEA Nano-Biotechnologies Infrastructure

R&D for biotechnology applications

The 5,500 sq. m nano-biotechnology platform deploys a full range of medical systems development know-how from sample surface preparation, biological analysis and substrate functionalization to packaging, microfluidics, microsystems, biological detection systems and component readers.

The platform’s R&D activities benefit scientific researchers, hospitals, and biomedical companies.

Its X-ray, gamma-ray, fluorescence, visible and lens-less imaging solutions ensure its unmatched performance in studying living organisms, tissues, cells and bacteria.

Its microsystems meet today's new needs for personalized medicine, nanomedicine and remote diagnostics. They can be implemented in vivo, embedded or implanted in medical devices.

The platform is located next to Clinatec and the Bioscience and Biotechnology Institute of Grenoble (BIG) and leverages BIG’s basic research. The platform files around 35 patents per year including for solutions developed under R&D contracts with some 30 industrial partners.